Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine add-on study in early relapsing-remitting multiple sclerosis on interferon-beta
2007-000503-15Phase 2Active
- Sponsor
- ARNAS Garibaldi
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of memantine in multiple sclerosis (MS) (2 arms), sponsored by ARNAS Garibaldi. Primary endpoints: Percentage reduction in whole brain volume, Percentage reduction in regional brain volume and 1 more. Started Apr 2007; status: active.
02
Drugs
memantine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2007-000503-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000503-15.